secwatch.observer — SEC 8-K summary
======================================

Issuer:     HTG MOLECULAR DIAGNOSTICS, INC (—)
CIK:        0001169987
Form:       8-K
Filed at:   2022-11-18T23:59:59+00:00
Accession:  0000950170-22-025443
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

HTG Molecular receives Nasdaq delisting notice for stockholders' equity below $2.5M
--------------------------------------------------------------------------------

- Nasdaq notified HTG Molecular on Nov 18, 2022 for non-compliance due to stockholders' equity falling below $2.5M as of Sept 30, 2022.
- Company has 45 calendar days, until Jan 2, 2023, to submit a plan to regain compliance with Nasdaq Rule 5550(b).
- If plan accepted, Nasdaq may grant up to 180-day extension from Notice date for evidence of compliance.
- No assurance that the Company will be able to regain compliance with the continued listing standard.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1169987/000095017022025443/0000950170-22-025443-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1169987/000095017022025443/htgm-20221118.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-025443

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer